Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 08, 2018 21:01 pm UTC| Business
MENLO PARK, Calif., Feb. 08, 2018 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of...
Park City Group Reports Fiscal Second Quarter 2018 Results
Feb 08, 2018 21:01 pm UTC| Business
Record Revenue of $5.7 Million, Driven by Growth Across All ServicesRecord GAAP Net Income to Common of $1.2 Million, or $0.06 Per-Share Management Reaffirms Outlook for Annual Growth and Expects Record Profitability ...
Nuance Announces First Quarter 2018 Results
Feb 08, 2018 21:00 pm UTC| Business
GAAP revenue of $501.6 million, up 2.9% over prior yearNon-GAAP revenue of $508.8 million, up 2.6% over prior yearOrganic revenue growth of 1% over the prior year GAAP diluted EPS of $0.18; Non-GAAP diluted EPS of $0.27Net...
Redfin to Announce Fourth-Quarter and Full-Year 2017 Results on February 22, 2018
Feb 08, 2018 21:00 pm UTC| Business
SEATTLE, Feb. 08, 2018 -- Redfin Corporation (NASDAQ:RDFN), a technology-powered residential real estate brokerage, will release fourth-quarter and full-year 2017 results after the stock market closes on Thursday,...
LRAD® Corporation Reports Record Fiscal First Quarter Revenues
Feb 08, 2018 21:00 pm UTC| Business
Fiscal First Quarter 2018 Highlights: Revenues of $7.6 million, an increase of 159% compared to the first fiscal quarter of 2017Operating income of $1.0 million, an increase of $2.3 million compared to the first fiscal...
Feb 08, 2018 21:00 pm UTC| Business
NEW YORK, Feb. 08, 2018 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Intel Corporation (NASDAQ:INTC) who purchased shares between July 27, 2017 and January 4,...
Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Feb 08, 2018 21:00 pm UTC| Business
BOSTON, Feb. 08, 2018 -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range...